Early detection means sustained quality of life for patients and reduced costs for society
Diabetes is pandemic – according to the World Diabetes Organization, more than 285 million people world-wide have diabetes today and the number is expected to double by the year of 20251. Many people with type 2 diabetes are unaware of their condition and could benefit from early detection and treatment. Primary care physicians and diabetes specialists play an important role in prevention, early detection and monitoring of diabetes and its complications.
Glucose testing is important in identifying the rapidly increasing number of people with diabetes at an early stage, and to monitor diabetes therapy. Severe complications such as renal and cardiovascular disease can be identified early by the recommended screening for microalbuminuria. Although anemia often accompanies diabetes and is a key indicator of renal disease, most patients with diabetes are rarely tested for it.
Three vital tests for screening, diagnosing or monitoring of diabetes, microalbuminuria and anemia are available from HemoCue®. Glucose, urine albumin and hemoglobin testing can be done quickly, easily and accurately in primary care settings using the HemoCue® systems.
Early detection - a primary health issue
Regular and targeted screening within primary health care is the best way to identify people with diabetes or those at risk of developing the disease. Early treatment of diabetes and its related complications means sustained quality of life for patients and reduced costs for society. HemoCue® test systems are reliable and accurate and enable immediate preventive action or subsequent treatment.
1 IDF Diabetes Atlas http://www.diabetesatlas.org/
Did you like this page? Share with others.